OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 4, Issue 2, 2010, Pages 132-138

  Lin, Zhenwu ^a   Nelson, Laurie ^a   Franke, Andre ^b   Poritz, Lisa ^a   Li, Tong Yi ^c   Wu, Rongling ^a   Wang, Yunhua ^a   MacNeill, Colin ^a   Thomas, Neal J ^a   Schreiber, Stefan ^b   Koltun, Walter A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c TOTAL   (France)

Author keywords

Familial IBD registry; Genetic association; Inflammatory bowel disease; L503F; OCTN; Organic cation transporter

Indexed keywords

GENE PRODUCT; PROTEIN OCTN1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; EXON; FAMILIAL DISEASE; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; ORGANIC CATION TRANSPORT PROTEINS; PENNSYLVANIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77952103249     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.09.003     Document Type: Article

References (46)

1. Russell R.K., Wilson D.C., and Satsangi J. Unravelling the complex genetics of inflammatory bowel disease. Arch Dis Child 89 (2004) 598-603
2. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nature Reviews. Immunology 8 (2008) 458-466
3. Russell R.K., Nimmo E.R., and Satsangi J. Molecular genetics of Crohn's disease. Curr Opin Genet Dev 14 (2004) 264-270
4. Schreiber S., Rosenstiel P., Albrecht M., Hampe J., and Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6 (2005) 376-388
5. Ley R.E., Peterson D.A., and Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006) 837-848
6. Van Limbergen J., Russell R.K., Nimmo E.R., Ho G.T., Arnott I.D., Wilson D.C., et al. Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 338-355
7. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.[see comment]. Nature 411 (2001) 599-603
8. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.[see comment]. Science 314 (2006) 1461-1463
9. Parkes M., Barrett J.C., Prescott N.J., Tremelling M., Anderson C.A., Fisher S.A., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.[see comment]. Nat Genet 39 (2007) 830-832
10. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39 (2007) 207-211
11. Garcia-Miranda P., Duran J.M., Peral M.J., and Ilundain A.A. Developmental maturation and segmental distribution of rat small intestinal l-carnitine uptake. J Membr Biol 206 (2005) 9-16
12. Kato Y., Sugiura M., Sugiura T., Wakayama T., Kubo Y., Kobayashi D., et al. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70 (2006) 829-837
13. Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419 (1997) 107-111
14. Fujiya M., Musch M.W., Nakagawa Y., Hu S., Alverdy J., Kohgo Y., et al. The Bacillus subtilis quorum-sensing milecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe 1 (2007) 299-308
15. Peltekova V.D., Wintle R.F., Rubin L.A., Amos C.I., Huang Q., Gu X., Newman B., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36 (2004) 471-475
16. Babusukumar U., Wang T., McGuire E., Broeckel U., and Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol 101 (2006) 1354-1361
17. Leung E., Hong J., Fraser A.G., Merriman T.R., Vishnu P., and Krissansen G.W. Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort. Immunol Cell Biol 84 (2006) 233-236
18. Palmieri O., Latiano A., Valvano R., D'Inca R., Vecchi M., Sturniolo G.C., et al. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 23 (2006) 497-506
19. Russell R.K., Drummond H.E., Nimmo E.R., Anderson N.H., Noble C.L., Wilson D.C., et al. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut 55 (2006) 1114-1123
20. Silverberg M.S., Duerr R.H., Brant S.R., Bromfield G., Datta L.W., Jani N., et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet 15 (2007) 328-335
21. Torok H.P., Glas J., Tonenchi L., Lohse P., Muller-Myhsok B., Limbersky O., et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.[see comment]. Gut 54 (2005) 1421-1427
22. Waller S., Tremelling M., Bredin F., Godfrey L., Howson J., and Parkes M. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 55 (2006) 809-814
23. Yamazaki K., Takazoe M., Tanaka T., Ichimori T., Saito S., Iida A., et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet 49 (2004) 664-668
24. Cucchiara S., Latiano A., Palmieri O., Staiano A.M., D'Inca R., Guariso G., et al. Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. World J Gastroenterol 13 (2007) 1221-1229
25. Fisher S.A., Hampe J., Onnie C.M., Daly M.J., Curley C., Purcell S., et al. Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Hum Mutat 27 (2006) 778-785
26. Torkvist L., Noble C.L., Lordal M., Sjoqvist U., Lindforss U., Nimmo E.R., et al. Contribution of the IBD5 locus to Crohn's disease in the Swedish population. Scand J Gastroenterol 42 (2007) 200-206
27. Bene J., Komlosi K., Magyari L., Talian G., Horvath K., Gasztonyi B., et al. Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes. Br J Nutr 98 (2007) 345-350
28. Ferraris A., Torres B., Knafelz D., Barabino A., Lionetti P., de Angelis G.L., et al. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study. Inflamm Bowel Dis 12 (2006) 355-361
29. Magyari L., Bene J., Komlosi K., Talian G., Farago B., Csongei V., et al. Prevalence of SLC22A4 1672T and SLC22A5 -207C combination defined TC haplotype in Hungarian ulcerative colitis patients. Pathol Oncol Res 13 (2007) 53-56
30. Noble C.L., Nimmo E.R., Drummond H., Ho G.T., Tenesa A., Smith L., et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129 (2005) 1854-1864
31. Vermeire S., Pierik M., Hlavaty T., Claessens G., van Schuerbeeck N., Joossens S., et al. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.[comment]. Gastroenterology 129 (2005) 1845-1853
32. Lin Z., Cui X., and Li H. Multiplex genotype determination at a large number of gene loci. Proc Natl Acad Sci U S A 93 (1996) 2582-2587
33. De la Vega F.M., Lazaruk K.D., Rhodes M.D., and Wenz M.H. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP genotyping assays and the SNPlex genotyping system. Mutat Res 573 (2005) 111-135
34. Tobler A.R., Short S., Andersen M.R., Paner T.M., Briggs J.C., Lambert S.M., et al. The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech 16 (2005) 398-406
35. Koltun W., Zhang W., Thompson J., Boyer M., Galka E., and Poritz L. Increased presence of NOD2 mutations in patients from a familial inflammatory bowel disease registry. Tripartite Colorectal Meeting. Dublin, Ireland (2005)
36. Lin Z., Poritz L., Franke A., Li T.-Y., Ruether A., Byrnes K.A., et al. Genetic association of DLG5 R30Q with familial and sporadic inflammatory bowel disease in men. Disease Markers 27 (2009) 1-9
37. Lin Z, Poritz L, Franke A, Li T-Y, Ruether A, Byrnes KA, et al. Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women. Digestive Diseases and Sciences 2009; Published online March 18.
38. Friedrichs F., Brescianini S., Annese V., Latiano A., Berger K., Kugathasan S., et al. Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet 119 (2006) 305-311
39. Chen S.C., and Rex D.K. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy.[see comment]. Am J Gastroenterol 102 (2007) 856-861
40. Shen B., Fazio V.W., Remzi F.H., Bennett A.E., Brzezinski A., Lopez R., et al. Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. Am J Gastroenterol 101 (2006) 2760-2768
41. Wu X., Prasad P.D., and Leibach F.H. Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246 (1998) 589-595
42. van Heel D.A., Udalova I.A., De Silva A.P., McGovern D.P., Kinouchi Y., Hull J., et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 11 (2002) 1281-1289
43. Bassler B.L., and Losick R. Bacterially speaking. Cell 125 (2006) 237-246
44. Camilli A., and Bassler B.L. Bacterial small-molecule signaling pathways. Science 311 (2006) 1113-1116
45. Kendall M.M., and Sperandio V. Quorum sensing by enteric pathogens. Curr Opin Gastroenterol 23 (2007) 10-15
46. Marx J. Biomedicine. Puzzling out the pains in the gut. Science 315 (2007) 33-35